

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 7.20395867 |
| 2 | regulation of female receptivity (GO:0045924) | 7.08560186 |
| 3 | female mating behavior (GO:0060180) | 6.08731630 |
| 4 | sodium ion export (GO:0071436) | 5.74991207 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.53485879 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.40139972 |
| 7 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.39377635 |
| 8 | detection of light stimulus involved in visual perception (GO:0050908) | 5.39377635 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.34971108 |
| 10 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 5.16770065 |
| 11 | aggressive behavior (GO:0002118) | 5.15868559 |
| 12 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.04335341 |
| 13 | cellular potassium ion homeostasis (GO:0030007) | 4.97522471 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.89048935 |
| 15 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.67763901 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.67635643 |
| 17 | definitive hemopoiesis (GO:0060216) | 4.62216266 |
| 18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.59554984 |
| 19 | regulation of synapse structural plasticity (GO:0051823) | 4.58716650 |
| 20 | cell communication by electrical coupling (GO:0010644) | 4.56863843 |
| 21 | vocalization behavior (GO:0071625) | 4.55538814 |
| 22 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.53562625 |
| 23 | protein localization to synapse (GO:0035418) | 4.46099559 |
| 24 | positive regulation of synapse maturation (GO:0090129) | 4.43811085 |
| 25 | endothelium development (GO:0003158) | 4.38027516 |
| 26 | response to pheromone (GO:0019236) | 4.29854036 |
| 27 | thrombin receptor signaling pathway (GO:0070493) | 4.26163133 |
| 28 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.20689312 |
| 29 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.12681095 |
| 30 | potassium ion homeostasis (GO:0055075) | 4.09714992 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.08005367 |
| 32 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.06587464 |
| 33 | cellular sodium ion homeostasis (GO:0006883) | 4.05283364 |
| 34 | synaptic vesicle endocytosis (GO:0048488) | 3.99712608 |
| 35 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.95999345 |
| 36 | retinal rod cell development (GO:0046548) | 3.90573304 |
| 37 | regulation of synaptic vesicle transport (GO:1902803) | 3.89901053 |
| 38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.87554913 |
| 39 | neurotransmitter secretion (GO:0007269) | 3.87134271 |
| 40 | locomotory exploration behavior (GO:0035641) | 3.86724285 |
| 41 | glutamate receptor signaling pathway (GO:0007215) | 3.85619000 |
| 42 | glutamate secretion (GO:0014047) | 3.81390145 |
| 43 | prepulse inhibition (GO:0060134) | 3.80336629 |
| 44 | regulation of synapse maturation (GO:0090128) | 3.76616431 |
| 45 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.74794191 |
| 46 | layer formation in cerebral cortex (GO:0021819) | 3.73706753 |
| 47 | striatum development (GO:0021756) | 3.71315636 |
| 48 | positive regulation of vasculogenesis (GO:2001214) | 3.65417253 |
| 49 | neuron cell-cell adhesion (GO:0007158) | 3.59761421 |
| 50 | innervation (GO:0060384) | 3.58417966 |
| 51 | relaxation of cardiac muscle (GO:0055119) | 3.55165588 |
| 52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.48552198 |
| 53 | membrane hyperpolarization (GO:0060081) | 3.47846909 |
| 54 | membrane depolarization during action potential (GO:0086010) | 3.45151154 |
| 55 | mating behavior (GO:0007617) | 3.42498298 |
| 56 | * relaxation of smooth muscle (GO:0044557) | 3.40416033 |
| 57 | regulation of neurotransmitter secretion (GO:0046928) | 3.37692778 |
| 58 | synapse assembly (GO:0007416) | 3.36474690 |
| 59 | neuron-neuron synaptic transmission (GO:0007270) | 3.34632828 |
| 60 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.34417782 |
| 61 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.34353538 |
| 62 | interkinetic nuclear migration (GO:0022027) | 3.31407592 |
| 63 | regulation of platelet aggregation (GO:0090330) | 3.30658815 |
| 64 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.29588788 |
| 65 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.28035926 |
| 66 | exploration behavior (GO:0035640) | 3.27818160 |
| 67 | synaptic transmission, glutamatergic (GO:0035249) | 3.27483422 |
| 68 | regulation of neurotransmitter transport (GO:0051588) | 3.26564725 |
| 69 | seminiferous tubule development (GO:0072520) | 3.26129514 |
| 70 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.25810987 |
| 71 | neurotransmitter transport (GO:0006836) | 3.22964097 |
| 72 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.22100730 |
| 73 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.21752765 |
| 74 | cell communication involved in cardiac conduction (GO:0086065) | 3.20278583 |
| 75 | calcium ion import (GO:0070509) | 3.19443395 |
| 76 | tachykinin receptor signaling pathway (GO:0007217) | 3.19414063 |
| 77 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.17690809 |
| 78 | dendrite morphogenesis (GO:0048813) | 3.15277302 |
| 79 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.14963605 |
| 80 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.13038963 |
| 81 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.09643036 |
| 82 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.09553936 |
| 83 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.09481310 |
| 84 | regulation of relaxation of muscle (GO:1901077) | 3.08605314 |
| 85 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.07292529 |
| 86 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.07292529 |
| 87 | monoamine transport (GO:0015844) | 3.06892709 |
| 88 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.06832544 |
| 89 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.06762336 |
| 90 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05731710 |
| 91 | cardiac myofibril assembly (GO:0055003) | 3.05588363 |
| 92 | positive regulation of granulocyte differentiation (GO:0030854) | 3.04873992 |
| 93 | multicellular organismal reproductive behavior (GO:0033057) | 3.04246880 |
| 94 | * relaxation of muscle (GO:0090075) | 3.02632956 |
| 95 | long-term synaptic potentiation (GO:0060291) | 3.02516610 |
| 96 | positive regulation of neurotransmitter transport (GO:0051590) | 3.00474495 |
| 97 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.00300699 |
| 98 | myofibril assembly (GO:0030239) | 3.00210319 |
| 99 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.99780069 |
| 100 | regulation of platelet activation (GO:0010543) | 2.99519413 |
| 101 | behavioral response to ethanol (GO:0048149) | 2.99350048 |
| 102 | synaptic vesicle transport (GO:0048489) | 2.99117716 |
| 103 | establishment of synaptic vesicle localization (GO:0097480) | 2.99117716 |
| 104 | potassium ion import (GO:0010107) | 2.98616400 |
| 105 | long-term memory (GO:0007616) | 2.98602011 |
| 106 | megakaryocyte development (GO:0035855) | 2.97217548 |
| 107 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.96690212 |
| 108 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.96557355 |
| 109 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.95759414 |
| 110 | positive regulation of membrane potential (GO:0045838) | 2.95096643 |
| 111 | maternal behavior (GO:0042711) | 2.94474396 |
| 112 | activation of protein kinase A activity (GO:0034199) | 2.93270995 |
| 113 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.92266417 |
| 114 | response to histamine (GO:0034776) | 2.91029675 |
| 115 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.90771427 |
| 116 | long term synaptic depression (GO:0060292) | 2.90511886 |
| 117 | regulation of postsynaptic membrane potential (GO:0060078) | 2.89849419 |
| 118 | carnitine transmembrane transport (GO:1902603) | 2.89675842 |
| 119 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.88736563 |
| 120 | dendritic spine morphogenesis (GO:0060997) | 2.88727221 |
| 121 | parental behavior (GO:0060746) | 2.88306301 |
| 122 | negative regulation of stress fiber assembly (GO:0051497) | 2.88234480 |
| 123 | urinary tract smooth muscle contraction (GO:0014848) | 2.87950726 |
| 124 | carnitine shuttle (GO:0006853) | 2.87839719 |
| 125 | negative regulation of heart rate (GO:0010459) | 2.87716086 |
| 126 | auditory behavior (GO:0031223) | 2.87502381 |
| 127 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.87209743 |
| 128 | behavioral response to cocaine (GO:0048148) | 2.86840042 |
| 129 | behavioral defense response (GO:0002209) | 2.85316447 |
| 130 | behavioral fear response (GO:0001662) | 2.85316447 |
| 131 | synaptic transmission, dopaminergic (GO:0001963) | 2.85166183 |
| 132 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.82475021 |
| 133 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.81005251 |
| 134 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.81005251 |
| 135 | regulation of vesicle fusion (GO:0031338) | 2.79618979 |
| 136 | cell migration in hindbrain (GO:0021535) | 2.78389983 |
| 137 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.77977728 |
| 138 | regulation of vasculogenesis (GO:2001212) | 2.77158954 |
| 139 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.77043616 |
| 140 | histamine secretion (GO:0001821) | 2.76360307 |
| 141 | cardiolipin metabolic process (GO:0032048) | 2.75353389 |
| 142 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.75251250 |
| 143 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.72375668 |
| 144 | adrenergic receptor signaling pathway (GO:0071875) | 2.68179186 |
| 145 | positive regulation of digestive system process (GO:0060456) | 2.67854860 |
| 146 | angiogenesis involved in wound healing (GO:0060055) | 2.66754194 |
| 147 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.66667469 |
| 148 | amino-acid betaine transport (GO:0015838) | 2.65483592 |
| 149 | carnitine transport (GO:0015879) | 2.65483592 |
| 150 | fatty acid transmembrane transport (GO:1902001) | 2.62387376 |
| 151 | blood coagulation, intrinsic pathway (GO:0007597) | 2.62337990 |
| 152 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.61373445 |
| 153 | positive regulation of B cell differentiation (GO:0045579) | 2.61216587 |
| 154 | cell differentiation involved in metanephros development (GO:0072202) | 2.59895252 |
| 155 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.58992591 |
| 156 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.58992591 |
| 157 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.58990931 |
| 158 | positive regulation of phosphatase activity (GO:0010922) | 2.58791716 |
| 159 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.54049127 |
| 160 | autophagic vacuole fusion (GO:0000046) | 2.54005401 |
| 161 | xenobiotic catabolic process (GO:0042178) | 2.52514360 |
| 162 | regulation of skeletal muscle contraction (GO:0014819) | 2.50583773 |
| 163 | positive regulation of steroid hormone secretion (GO:2000833) | 2.50366585 |
| 164 | positive regulation of cation channel activity (GO:2001259) | 2.47563442 |
| 165 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.47338498 |
| 166 | cardiac muscle hypertrophy (GO:0003300) | 2.47054307 |
| 167 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.45491223 |
| 168 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.43644574 |
| 169 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.42911428 |
| 170 | glomerular filtration (GO:0003094) | 2.42830557 |
| 171 | histamine transport (GO:0051608) | 2.41424790 |
| 172 | regulation of memory T cell differentiation (GO:0043380) | 2.35365605 |
| 173 | neutrophil activation involved in immune response (GO:0002283) | 2.34872401 |
| 174 | striated muscle hypertrophy (GO:0014897) | 2.34503955 |
| 175 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.32837783 |
| 176 | negative regulation of hormone metabolic process (GO:0032351) | 2.31526747 |
| 177 | positive regulation of protein homodimerization activity (GO:0090073) | 2.29865613 |
| 178 | negative regulation of platelet activation (GO:0010544) | 2.29594099 |
| 179 | regulation of lipoprotein metabolic process (GO:0050746) | 2.28059924 |
| 180 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.26998825 |
| 181 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.26998825 |
| 182 | adenosine metabolic process (GO:0046085) | 2.25903086 |
| 183 | dopamine transport (GO:0015872) | 2.23195378 |
| 184 | quaternary ammonium group transport (GO:0015697) | 2.22562759 |
| 185 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.19748048 |
| 186 | detection of calcium ion (GO:0005513) | 2.18413371 |
| 187 | muscle hypertrophy (GO:0014896) | 2.17909887 |
| 188 | positive regulation of vascular permeability (GO:0043117) | 2.17834202 |
| 189 | organelle membrane fusion (GO:0090174) | 2.17548236 |
| 190 | growth hormone receptor signaling pathway (GO:0060396) | 2.17408906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.09323701 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.87467099 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.09748121 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.03583603 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.03123192 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.99536752 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.95251385 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.88043438 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75230144 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.70631157 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.66445246 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.63698678 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.63698678 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.58123779 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55582893 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.48580660 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47152801 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.45993225 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45874522 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.40412300 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.37045246 |
| 22 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.36827784 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.31993671 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31579672 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.27303337 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.24047478 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.16656713 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15487866 |
| 29 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.12049954 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.08434507 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.07881596 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93465385 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.92963924 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.91868881 |
| 35 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.86023561 |
| 36 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.82671399 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80623689 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.79284048 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.77487522 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76379202 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.73127659 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72781176 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.71782834 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71250156 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.70828170 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69576579 |
| 47 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.67688009 |
| 48 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.63119299 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58733479 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.58726204 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.58726204 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.56241499 |
| 53 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.55086155 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54700438 |
| 55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54165310 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53008801 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52651911 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48453568 |
| 59 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47831693 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47593892 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45867173 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45568364 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38190606 |
| 64 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37558093 |
| 65 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.36833620 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36494208 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35814260 |
| 68 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.32437231 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32082880 |
| 70 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28736454 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28538134 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27903390 |
| 73 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.27178991 |
| 74 | * AR_19668381_ChIP-Seq_PC3_Human | 1.25526587 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23726801 |
| 76 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23642426 |
| 77 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.23043741 |
| 78 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.21195240 |
| 79 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20930681 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19850902 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18958665 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18868096 |
| 83 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17794044 |
| 84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17546194 |
| 85 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16656124 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15953019 |
| 87 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15868060 |
| 88 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15817736 |
| 89 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.14654055 |
| 90 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.14443188 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14250550 |
| 92 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14250550 |
| 93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14117985 |
| 94 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12072204 |
| 95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11762158 |
| 96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11398004 |
| 97 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.11359951 |
| 98 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10240823 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10224401 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10020943 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09946002 |
| 102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09005064 |
| 103 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.08880703 |
| 104 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08760250 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08535724 |
| 106 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06923594 |
| 107 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06710331 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06507328 |
| 109 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.06408488 |
| 110 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06135998 |
| 111 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06005226 |
| 112 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05924580 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05776105 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05307123 |
| 115 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04693806 |
| 116 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04687754 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04177131 |
| 118 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03680667 |
| 119 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03410101 |
| 120 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02591719 |
| 121 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02485974 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02479887 |
| 123 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01855483 |
| 124 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01331036 |
| 125 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01279827 |
| 126 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00839275 |
| 127 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00644660 |
| 128 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00614833 |
| 129 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00454243 |
| 130 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00403583 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00181447 |
| 132 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.99991500 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98127543 |
| 134 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97472369 |
| 135 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96942431 |
| 136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96488015 |
| 137 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96325635 |
| 138 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95737461 |
| 139 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95497588 |
| 140 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92901587 |
| 141 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92643465 |
| 142 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92510429 |
| 143 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92510429 |
| 144 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91887998 |
| 145 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91706579 |
| 146 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89609703 |
| 147 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89448455 |
| 148 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.89393363 |
| 149 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89234929 |
| 150 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89234929 |
| 151 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88691601 |
| 152 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88269813 |
| 153 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87848432 |
| 154 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87719742 |
| 155 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87557815 |
| 156 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87440529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.47887881 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 3.67724139 |
| 3 | * MP0005464_abnormal_platelet_physiology | 3.46714289 |
| 4 | MP0002822_catalepsy | 3.43266133 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.41192526 |
| 6 | MP0003880_abnormal_central_pattern | 3.33632748 |
| 7 | MP0002090_abnormal_vision | 3.06210402 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.90562748 |
| 9 | MP0009745_abnormal_behavioral_response | 2.79396337 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.77234122 |
| 11 | MP0003724_increased_susceptibility_to | 2.64936278 |
| 12 | MP0001984_abnormal_olfaction | 2.55307481 |
| 13 | MP0002064_seizures | 2.54859835 |
| 14 | MP0006072_abnormal_retinal_apoptosis | 2.52934958 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 2.45617950 |
| 16 | MP0004270_analgesia | 2.43955894 |
| 17 | MP0002009_preneoplasia | 2.43057509 |
| 18 | MP0009046_muscle_twitch | 2.42119760 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.41467264 |
| 20 | MP0001486_abnormal_startle_reflex | 2.41003319 |
| 21 | MP0001502_abnormal_circadian_rhythm | 2.39788780 |
| 22 | MP0002272_abnormal_nervous_system | 2.32677968 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.30498948 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.28380194 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 2.25842881 |
| 26 | MP0001545_abnormal_hematopoietic_system | 2.25842881 |
| 27 | MP0008004_abnormal_stomach_pH | 2.21346128 |
| 28 | MP0002572_abnormal_emotion/affect_behav | 2.18174992 |
| 29 | MP0004084_abnormal_cardiac_muscle | 2.05753017 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.95721447 |
| 31 | MP0005220_abnormal_exocrine_pancreas | 1.94358241 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.85001591 |
| 33 | MP0001188_hyperpigmentation | 1.84766458 |
| 34 | MP0002638_abnormal_pupillary_reflex | 1.84513894 |
| 35 | MP0004510_myositis | 1.78451397 |
| 36 | MP0004036_abnormal_muscle_relaxation | 1.77725247 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.76708130 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.75349888 |
| 39 | MP0002184_abnormal_innervation | 1.74272633 |
| 40 | MP0004233_abnormal_muscle_weight | 1.73509235 |
| 41 | MP0002067_abnormal_sensory_capabilities | 1.71316493 |
| 42 | MP0005253_abnormal_eye_physiology | 1.67462500 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.64846457 |
| 44 | MP0008569_lethality_at_weaning | 1.63336441 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.58135492 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.57412010 |
| 47 | MP0004085_abnormal_heartbeat | 1.57302003 |
| 48 | MP0003879_abnormal_hair_cell | 1.53895196 |
| 49 | MP0005386_behavior/neurological_phenoty | 1.53808369 |
| 50 | MP0004924_abnormal_behavior | 1.53808369 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.53439058 |
| 52 | MP0002736_abnormal_nociception_after | 1.51056911 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.50741932 |
| 54 | MP0003283_abnormal_digestive_organ | 1.48462480 |
| 55 | MP0009697_abnormal_copulation | 1.45706853 |
| 56 | MP0001970_abnormal_pain_threshold | 1.45587904 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.43569989 |
| 58 | MP0005410_abnormal_fertilization | 1.43422097 |
| 59 | MP0003122_maternal_imprinting | 1.39037941 |
| 60 | MP0004782_abnormal_surfactant_physiolog | 1.38364248 |
| 61 | MP0005195_abnormal_posterior_eye | 1.37397375 |
| 62 | MP0004811_abnormal_neuron_physiology | 1.37371373 |
| 63 | MP0003828_pulmonary_edema | 1.35238102 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.34830002 |
| 65 | MP0002882_abnormal_neuron_morphology | 1.34322134 |
| 66 | MP0001440_abnormal_grooming_behavior | 1.34314933 |
| 67 | MP0000778_abnormal_nervous_system | 1.33392336 |
| 68 | MP0000751_myopathy | 1.33199372 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 1.31194282 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.30658139 |
| 71 | MP0000013_abnormal_adipose_tissue | 1.28596668 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.28333005 |
| 73 | MP0000516_abnormal_urinary_system | 1.28195653 |
| 74 | MP0005367_renal/urinary_system_phenotyp | 1.28195653 |
| 75 | MP0001529_abnormal_vocalization | 1.27709080 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 1.27477219 |
| 77 | MP0000383_abnormal_hair_follicle | 1.26652910 |
| 78 | MP0001851_eye_inflammation | 1.26620648 |
| 79 | MP0002006_tumorigenesis | 1.26304299 |
| 80 | MP0002733_abnormal_thermal_nociception | 1.25107857 |
| 81 | MP0003045_fibrosis | 1.24004061 |
| 82 | MP0004858_abnormal_nervous_system | 1.21863220 |
| 83 | MP0004130_abnormal_muscle_cell | 1.21828168 |
| 84 | MP0000955_abnormal_spinal_cord | 1.21645686 |
| 85 | MP0005165_increased_susceptibility_to | 1.20630589 |
| 86 | MP0003633_abnormal_nervous_system | 1.19420978 |
| 87 | MP0005275_abnormal_skin_tensile | 1.19013731 |
| 88 | MP0005620_abnormal_muscle_contractility | 1.17853753 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 1.17755039 |
| 90 | MP0004885_abnormal_endolymph | 1.17404500 |
| 91 | MP0001835_abnormal_antigen_presentation | 1.16663131 |
| 92 | MP0009278_abnormal_bone_marrow | 1.16569168 |
| 93 | MP0006276_abnormal_autonomic_nervous | 1.16494815 |
| 94 | MP0001756_abnormal_urination | 1.15494710 |
| 95 | MP0000372_irregular_coat_pigmentation | 1.15476566 |
| 96 | MP0005248_abnormal_Harderian_gland | 1.15132322 |
| 97 | MP0003137_abnormal_impulse_conducting | 1.15015277 |
| 98 | MP0003195_calcinosis | 1.14748075 |
| 99 | MP0005330_cardiomyopathy | 1.14244328 |
| 100 | MP0002735_abnormal_chemical_nociception | 1.13450662 |
| 101 | MP0005385_cardiovascular_system_phenoty | 1.12648656 |
| 102 | MP0001544_abnormal_cardiovascular_syste | 1.12648656 |
| 103 | MP0002693_abnormal_pancreas_physiology | 1.12441693 |
| 104 | MP0001177_atelectasis | 1.11542419 |
| 105 | MP0002229_neurodegeneration | 1.10734161 |
| 106 | MP0002752_abnormal_somatic_nervous | 1.09397049 |
| 107 | * MP0008775_abnormal_heart_ventricle | 1.08817910 |
| 108 | MP0002234_abnormal_pharynx_morphology | 1.07592720 |
| 109 | MP0002066_abnormal_motor_capabilities/c | 1.07026670 |
| 110 | MP0005535_abnormal_body_temperature | 1.05671104 |
| 111 | MP0001765_abnormal_ion_homeostasis | 1.05245885 |
| 112 | MP0006292_abnormal_olfactory_placode | 1.04458930 |
| 113 | MP0002148_abnormal_hypersensitivity_rea | 1.03058345 |
| 114 | MP0004043_abnormal_pH_regulation | 1.02371026 |
| 115 | MP0002132_abnormal_respiratory_system | 1.01406979 |
| 116 | MP0003183_abnormal_peptide_metabolism | 1.00669208 |
| 117 | MP0000681_abnormal_thyroid_gland | 0.97457413 |
| 118 | MP0003329_amyloid_beta_deposits | 0.97082162 |
| 119 | MP0006138_congestive_heart_failure | 0.95496410 |
| 120 | MP0000534_abnormal_ureter_morphology | 0.95230449 |
| 121 | MP0004145_abnormal_muscle_electrophysio | 0.95135684 |
| 122 | MP0002152_abnormal_brain_morphology | 0.93145545 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.92837498 |
| 124 | MP0006036_abnormal_mitochondrial_physio | 0.90728993 |
| 125 | MP0003866_abnormal_defecation | 0.90665441 |
| 126 | * MP0005595_abnormal_vascular_smooth | 0.90169570 |
| 127 | MP0002332_abnormal_exercise_endurance | 0.89660382 |
| 128 | MP0005409_darkened_coat_color | 0.87743676 |
| 129 | MP0005645_abnormal_hypothalamus_physiol | 0.87493402 |
| 130 | MP0003787_abnormal_imprinting | 0.86629103 |
| 131 | MP0003631_nervous_system_phenotype | 0.85643748 |
| 132 | MP0001661_extended_life_span | 0.85055177 |
| 133 | MP0010678_abnormal_skin_adnexa | 0.84191010 |
| 134 | MP0008872_abnormal_physiological_respon | 0.83565600 |
| 135 | MP0001664_abnormal_digestion | 0.83384060 |
| 136 | MP0002972_abnormal_cardiac_muscle | 0.82272914 |
| 137 | MP0003303_peritoneal_inflammation | 0.82088928 |
| 138 | MP0002069_abnormal_eating/drinking_beha | 0.81936086 |
| 139 | MP0005499_abnormal_olfactory_system | 0.80334101 |
| 140 | MP0005394_taste/olfaction_phenotype | 0.80334101 |
| 141 | MP0005167_abnormal_blood-brain_barrier | 0.79888403 |
| 142 | MP0000462_abnormal_digestive_system | 0.78576011 |
| 143 | MP0003634_abnormal_glial_cell | 0.78552794 |
| 144 | MP0005623_abnormal_meninges_morphology | 0.76791333 |
| 145 | MP0002128_abnormal_blood_circulation | 0.76600786 |
| 146 | MP0005503_abnormal_tendon_morphology | 0.74898402 |
| 147 | MP0005670_abnormal_white_adipose | 0.74551671 |
| 148 | MP0006054_spinal_hemorrhage | 0.74419359 |
| 149 | MP0010630_abnormal_cardiac_muscle | 0.73904547 |
| 150 | MP0004484_altered_response_of | 0.72309835 |
| 151 | MP0004142_abnormal_muscle_tone | 0.70414505 |
| 152 | MP0003075_altered_response_to | 0.70379673 |
| 153 | MP0005647_abnormal_sex_gland | 0.69407494 |
| 154 | MP0005187_abnormal_penis_morphology | 0.68378266 |
| 155 | * MP0000230_abnormal_systemic_arterial | 0.67979662 |
| 156 | MP0005084_abnormal_gallbladder_morpholo | 0.65238070 |
| 157 | MP0000538_abnormal_urinary_bladder | 0.65182503 |
| 158 | MP0008874_decreased_physiological_sensi | 0.65101428 |
| 159 | MP0002078_abnormal_glucose_homeostasis | 0.64698958 |
| 160 | MP0004742_abnormal_vestibular_system | 0.63533403 |
| 161 | MP0001963_abnormal_hearing_physiology | 0.62505363 |
| 162 | MP0002127_abnormal_cardiovascular_syste | 0.61905252 |
| 163 | MP0001905_abnormal_dopamine_level | 0.61376927 |
| 164 | MP0001943_abnormal_respiration | 0.60585769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 9.63903868 |
| 2 | Prolonged bleeding time (HP:0003010) | 6.18642646 |
| 3 | Central scotoma (HP:0000603) | 5.43683194 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.32576040 |
| 5 | Right ventricular cardiomyopathy (HP:0011663) | 5.25293411 |
| 6 | Focal motor seizures (HP:0011153) | 4.71022345 |
| 7 | Myokymia (HP:0002411) | 4.59106648 |
| 8 | Febrile seizures (HP:0002373) | 4.53395772 |
| 9 | Increased mean platelet volume (HP:0011877) | 4.34539071 |
| 10 | Severe visual impairment (HP:0001141) | 4.31271837 |
| 11 | Menorrhagia (HP:0000132) | 4.05114401 |
| 12 | Visual hallucinations (HP:0002367) | 4.04893362 |
| 13 | Absence seizures (HP:0002121) | 4.01944685 |
| 14 | Petechiae (HP:0000967) | 3.98688333 |
| 15 | Abnormality of macular pigmentation (HP:0008002) | 3.95366701 |
| 16 | Abnormal platelet volume (HP:0011876) | 3.95067404 |
| 17 | Bundle branch block (HP:0011710) | 3.83644542 |
| 18 | Scotoma (HP:0000575) | 3.79153378 |
| 19 | Focal seizures (HP:0007359) | 3.78211240 |
| 20 | Epistaxis (HP:0000421) | 3.77418137 |
| 21 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.68428590 |
| 22 | Metaphyseal dysplasia (HP:0100255) | 3.60867433 |
| 23 | Sudden death (HP:0001699) | 3.49385795 |
| 24 | Purpura (HP:0000979) | 3.44928263 |
| 25 | Dialeptic seizures (HP:0011146) | 3.38998969 |
| 26 | Ventricular tachycardia (HP:0004756) | 3.33081336 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 3.30658119 |
| 28 | Gingival bleeding (HP:0000225) | 3.24023741 |
| 29 | Calf muscle hypertrophy (HP:0008981) | 3.19564933 |
| 30 | Prolonged QT interval (HP:0001657) | 3.16314780 |
| 31 | Septo-optic dysplasia (HP:0100842) | 3.12183302 |
| 32 | Abnormality of the prostate (HP:0008775) | 3.11642286 |
| 33 | Decreased central vision (HP:0007663) | 3.05351001 |
| 34 | Dysdiadochokinesis (HP:0002075) | 3.04056896 |
| 35 | Mutism (HP:0002300) | 3.02756382 |
| 36 | Depression (HP:0000716) | 3.01713419 |
| 37 | Action tremor (HP:0002345) | 3.00682880 |
| 38 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.94683109 |
| 39 | Ketoacidosis (HP:0001993) | 2.87128884 |
| 40 | Generalized tonic-clonic seizures (HP:0002069) | 2.85812332 |
| 41 | Renal cortical cysts (HP:0000803) | 2.82131314 |
| 42 | Torticollis (HP:0000473) | 2.81240738 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 2.80696226 |
| 44 | Palpitations (HP:0001962) | 2.79060987 |
| 45 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.75039905 |
| 46 | Atonic seizures (HP:0010819) | 2.74952124 |
| 47 | Autoimmune hemolytic anemia (HP:0001890) | 2.68635434 |
| 48 | Decreased circulating renin level (HP:0003351) | 2.68569566 |
| 49 | Ankle clonus (HP:0011448) | 2.63703444 |
| 50 | Hyperthyroidism (HP:0000836) | 2.63652897 |
| 51 | Acute lymphatic leukemia (HP:0006721) | 2.62373390 |
| 52 | Anxiety (HP:0000739) | 2.61973272 |
| 53 | Prostate neoplasm (HP:0100787) | 2.60525647 |
| 54 | Scanning speech (HP:0002168) | 2.56433026 |
| 55 | Broad-based gait (HP:0002136) | 2.55517870 |
| 56 | Ventricular arrhythmia (HP:0004308) | 2.55190714 |
| 57 | Genetic anticipation (HP:0003743) | 2.54595392 |
| 58 | Poor eye contact (HP:0000817) | 2.51317572 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.50548030 |
| 60 | Abnormality of the renal cortex (HP:0011035) | 2.49495168 |
| 61 | Heart block (HP:0012722) | 2.45227255 |
| 62 | Abnormal EKG (HP:0003115) | 2.43600267 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 2.43198001 |
| 64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.42943312 |
| 65 | Supranuclear gaze palsy (HP:0000605) | 2.42864218 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.42122171 |
| 67 | Cholecystitis (HP:0001082) | 2.42122171 |
| 68 | Agammaglobulinemia (HP:0004432) | 2.42010159 |
| 69 | Hypothermia (HP:0002045) | 2.41283935 |
| 70 | Ketosis (HP:0001946) | 2.40598107 |
| 71 | Drooling (HP:0002307) | 2.38966308 |
| 72 | Excessive salivation (HP:0003781) | 2.38966308 |
| 73 | Atrial fibrillation (HP:0005110) | 2.37759681 |
| 74 | Abnormality of the calf musculature (HP:0001430) | 2.27504326 |
| 75 | Stomach cancer (HP:0012126) | 2.26432109 |
| 76 | Primary atrial arrhythmia (HP:0001692) | 2.26060690 |
| 77 | Focal dystonia (HP:0004373) | 2.23901695 |
| 78 | Abnormal social behavior (HP:0012433) | 2.20027947 |
| 79 | Impaired social interactions (HP:0000735) | 2.20027947 |
| 80 | Abnormal eating behavior (HP:0100738) | 2.19502226 |
| 81 | Abolished electroretinogram (ERG) (HP:0000550) | 2.18376380 |
| 82 | Abnormal pupillary function (HP:0007686) | 2.18326031 |
| 83 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.18167631 |
| 84 | Craniofacial dystonia (HP:0012179) | 2.16970009 |
| 85 | Neoplasm of the heart (HP:0100544) | 2.16617492 |
| 86 | Acute myeloid leukemia (HP:0004808) | 2.15978311 |
| 87 | Truncal ataxia (HP:0002078) | 2.14081794 |
| 88 | Supraventricular tachycardia (HP:0004755) | 2.13775447 |
| 89 | Gaze-evoked nystagmus (HP:0000640) | 2.13509186 |
| 90 | Limb dystonia (HP:0002451) | 2.13407815 |
| 91 | Testicular neoplasm (HP:0010788) | 2.13211496 |
| 92 | Supraventricular arrhythmia (HP:0005115) | 2.11019384 |
| 93 | Severe Myopia (HP:0011003) | 2.10594477 |
| 94 | Gait imbalance (HP:0002141) | 2.09088449 |
| 95 | Spontaneous abortion (HP:0005268) | 2.08954896 |
| 96 | Postural instability (HP:0002172) | 2.08140279 |
| 97 | Hyperventilation (HP:0002883) | 2.07614895 |
| 98 | Broad metatarsal (HP:0001783) | 2.07070590 |
| 99 | Rimmed vacuoles (HP:0003805) | 2.06614329 |
| 100 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.04899654 |
| 101 | Hemiplegia (HP:0002301) | 2.04889185 |
| 102 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.03084899 |
| 103 | Hypoplasia of the fovea (HP:0007750) | 2.03084899 |
| 104 | Abnormal atrioventricular conduction (HP:0005150) | 2.03001306 |
| 105 | Polyphagia (HP:0002591) | 2.02556876 |
| 106 | Absent speech (HP:0001344) | 2.01211765 |
| 107 | Hypoglycemic coma (HP:0001325) | 1.98540251 |
| 108 | Dysmetria (HP:0001310) | 1.98288255 |
| 109 | Incomplete penetrance (HP:0003829) | 1.97907556 |
| 110 | Stereotypic behavior (HP:0000733) | 1.97561898 |
| 111 | Annular pancreas (HP:0001734) | 1.96249120 |
| 112 | Ventricular fibrillation (HP:0001663) | 1.95455306 |
| 113 | Abnormal platelet function (HP:0011869) | 1.94900947 |
| 114 | Impaired platelet aggregation (HP:0003540) | 1.94900947 |
| 115 | Papilledema (HP:0001085) | 1.94777556 |
| 116 | Long toe (HP:0010511) | 1.94019719 |
| 117 | Thyroid-stimulating hormone excess (HP:0002925) | 1.93644178 |
| 118 | Hypsarrhythmia (HP:0002521) | 1.92705303 |
| 119 | Thyroiditis (HP:0100646) | 1.92211745 |
| 120 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.90691944 |
| 121 | Amblyopia (HP:0000646) | 1.90649523 |
| 122 | Abnormality of B cell number (HP:0010975) | 1.90443628 |
| 123 | Exercise-induced myalgia (HP:0003738) | 1.89604506 |
| 124 | Metabolic alkalosis (HP:0200114) | 1.87406933 |
| 125 | Agitation (HP:0000713) | 1.87357950 |
| 126 | Dyschromatopsia (HP:0007641) | 1.86595978 |
| 127 | Dilated cardiomyopathy (HP:0001644) | 1.86227571 |
| 128 | Papillary thyroid carcinoma (HP:0002895) | 1.84014417 |
| 129 | Polydipsia (HP:0001959) | 1.83344104 |
| 130 | Abnormal drinking behavior (HP:0030082) | 1.83344104 |
| 131 | Bradykinesia (HP:0002067) | 1.83008435 |
| 132 | Elfin facies (HP:0004428) | 1.82714555 |
| 133 | Hyperglycemia (HP:0003074) | 1.82082391 |
| 134 | Abnormality of the lower motor neuron (HP:0002366) | 1.79695959 |
| 135 | Thrombocytosis (HP:0001894) | 1.79260898 |
| 136 | Abnormality of male internal genitalia (HP:0000022) | 1.78035980 |
| 137 | Insomnia (HP:0100785) | 1.77136598 |
| 138 | Syncope (HP:0001279) | 1.77059702 |
| 139 | Pointed chin (HP:0000307) | 1.76396240 |
| 140 | Bruising susceptibility (HP:0000978) | 1.76216544 |
| 141 | Impaired smooth pursuit (HP:0007772) | 1.76190454 |
| 142 | Flat cornea (HP:0007720) | 1.75883083 |
| 143 | Abnormality of renin-angiotensin system (HP:0000847) | 1.75606173 |
| 144 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.75160410 |
| 145 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.75160410 |
| 146 | Anhidrosis (HP:0000970) | 1.74517175 |
| 147 | Portal hypertension (HP:0001409) | 1.74391741 |
| 148 | Atrioventricular block (HP:0001678) | 1.74315825 |
| 149 | Pancreatic fibrosis (HP:0100732) | 1.74192265 |
| 150 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.74127414 |
| 151 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.73747665 |
| 152 | Increased corneal curvature (HP:0100692) | 1.73738993 |
| 153 | Keratoconus (HP:0000563) | 1.73738993 |
| 154 | Spinal canal stenosis (HP:0003416) | 1.73723141 |
| 155 | Intention tremor (HP:0002080) | 1.73141083 |
| 156 | Retinal dysplasia (HP:0007973) | 1.73072600 |
| 157 | Hypoproteinemia (HP:0003075) | 1.72636794 |
| 158 | Poikilocytosis (HP:0004447) | 1.72418170 |
| 159 | Hepatoblastoma (HP:0002884) | 1.71505814 |
| 160 | Facial diplegia (HP:0001349) | 1.71112998 |
| 161 | Short chin (HP:0000331) | 1.70908413 |
| 162 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.70605159 |
| 163 | Sudden cardiac death (HP:0001645) | 1.70141732 |
| 164 | Hypokalemic alkalosis (HP:0001949) | 1.69849813 |
| 165 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.69222123 |
| 166 | Fetal akinesia sequence (HP:0001989) | 1.69151057 |
| 167 | Abnormality of the renal medulla (HP:0100957) | 1.68770393 |
| 168 | Pigmentary retinal degeneration (HP:0001146) | 1.68757224 |
| 169 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.68583933 |
| 170 | Dysmetric saccades (HP:0000641) | 1.67896527 |
| 171 | Progressive inability to walk (HP:0002505) | 1.67309695 |
| 172 | Attenuation of retinal blood vessels (HP:0007843) | 1.67005893 |
| 173 | Abnormality of the fovea (HP:0000493) | 1.66679309 |
| 174 | Left ventricular hypertrophy (HP:0001712) | 1.66152957 |
| 175 | Bradycardia (HP:0001662) | 1.66075802 |
| 176 | Optic nerve hypoplasia (HP:0000609) | 1.65792144 |
| 177 | Asymmetric septal hypertrophy (HP:0001670) | 1.65689307 |
| 178 | Megalencephaly (HP:0001355) | 1.65626425 |
| 179 | Lipoatrophy (HP:0100578) | 1.65625574 |
| 180 | Status epilepticus (HP:0002133) | 1.65273682 |
| 181 | Absent septum pellucidum (HP:0001331) | 1.64674974 |
| 182 | Biliary tract neoplasm (HP:0100574) | 1.64583477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.24575600 |
| 2 | TAOK3 | 4.05489977 |
| 3 | EPHA4 | 3.75034914 |
| 4 | KIT | 3.11460574 |
| 5 | FLT3 | 3.11075590 |
| 6 | OBSCN | 3.09545446 |
| 7 | MAP3K9 | 2.92591334 |
| 8 | PRPF4B | 2.82762243 |
| 9 | NTRK3 | 2.79921168 |
| 10 | MAP3K4 | 2.67317431 |
| 11 | MINK1 | 2.61575748 |
| 12 | PAK6 | 2.41334570 |
| 13 | DAPK2 | 2.31518611 |
| 14 | TEC | 2.27139148 |
| 15 | CASK | 2.13259322 |
| 16 | PHKG2 | 2.06663076 |
| 17 | PHKG1 | 2.06663076 |
| 18 | BCKDK | 1.79274803 |
| 19 | RIPK1 | 1.77518664 |
| 20 | PKN2 | 1.75738581 |
| 21 | TNIK | 1.72845899 |
| 22 | NUAK1 | 1.70667191 |
| 23 | TRPM7 | 1.69764783 |
| 24 | MAP2K7 | 1.68678604 |
| 25 | NTRK2 | 1.66666945 |
| 26 | PIK3CG | 1.62294246 |
| 27 | CAMKK1 | 1.61549634 |
| 28 | MAP4K2 | 1.60007722 |
| 29 | GRK1 | 1.59361181 |
| 30 | MST4 | 1.56492064 |
| 31 | SYK | 1.54122949 |
| 32 | NTRK1 | 1.53224026 |
| 33 | ADRBK2 | 1.52399695 |
| 34 | KSR2 | 1.49425796 |
| 35 | PIK3CA | 1.48666873 |
| 36 | TIE1 | 1.41027198 |
| 37 | CDK5 | 1.39924107 |
| 38 | KSR1 | 1.38763524 |
| 39 | CSF1R | 1.33795104 |
| 40 | CAMK1 | 1.31409520 |
| 41 | DYRK1A | 1.31223341 |
| 42 | BTK | 1.29866092 |
| 43 | MAPK13 | 1.26713996 |
| 44 | SGK223 | 1.24389144 |
| 45 | SGK494 | 1.24389144 |
| 46 | MYLK | 1.19948519 |
| 47 | STK39 | 1.19867143 |
| 48 | STK38 | 1.19855512 |
| 49 | MAP3K13 | 1.18461277 |
| 50 | PRKD3 | 1.16348148 |
| 51 | ITK | 1.14525373 |
| 52 | FES | 1.14402390 |
| 53 | INSRR | 1.14098983 |
| 54 | MAP2K4 | 1.13500152 |
| 55 | CAMKK2 | 1.10375269 |
| 56 | NEK1 | 1.09375705 |
| 57 | RIPK4 | 1.05808490 |
| 58 | TAOK2 | 1.05264072 |
| 59 | PINK1 | 1.04906550 |
| 60 | DAPK1 | 1.03678750 |
| 61 | PRKCG | 1.03607110 |
| 62 | AKT3 | 1.03311909 |
| 63 | DMPK | 1.03014559 |
| 64 | SGK2 | 0.99937823 |
| 65 | CAMK2A | 0.96179786 |
| 66 | EPHA3 | 0.95921412 |
| 67 | LATS1 | 0.93726530 |
| 68 | CAMK1G | 0.93145875 |
| 69 | SCYL2 | 0.91412121 |
| 70 | MARK2 | 0.91303994 |
| 71 | PAK3 | 0.90212833 |
| 72 | GRK5 | 0.89994732 |
| 73 | MAP3K12 | 0.89327256 |
| 74 | IRAK1 | 0.89127876 |
| 75 | FGFR3 | 0.89004839 |
| 76 | TBK1 | 0.87673398 |
| 77 | MAPKAPK3 | 0.87439290 |
| 78 | CDK14 | 0.86393168 |
| 79 | ARAF | 0.86246190 |
| 80 | STK38L | 0.85429480 |
| 81 | BMPR2 | 0.84624025 |
| 82 | PRKCE | 0.83522391 |
| 83 | SIK2 | 0.83346339 |
| 84 | CDK18 | 0.82660298 |
| 85 | CDK15 | 0.82190160 |
| 86 | PLK2 | 0.81602663 |
| 87 | SGK3 | 0.81340784 |
| 88 | ERBB3 | 0.79293483 |
| 89 | CAMK2D | 0.78123944 |
| 90 | PTK2B | 0.76468706 |
| 91 | HIPK2 | 0.76310877 |
| 92 | MAP3K7 | 0.74097944 |
| 93 | CAMK4 | 0.73905045 |
| 94 | MAP3K1 | 0.72563723 |
| 95 | TNK2 | 0.72074900 |
| 96 | CAMK1D | 0.69877587 |
| 97 | GRK7 | 0.68507791 |
| 98 | CDK11A | 0.67819953 |
| 99 | SGK1 | 0.67026676 |
| 100 | IKBKB | 0.66831289 |
| 101 | PRKD1 | 0.65357830 |
| 102 | CDC42BPA | 0.64948638 |
| 103 | WNK3 | 0.64815940 |
| 104 | RAF1 | 0.63728147 |
| 105 | UHMK1 | 0.62346835 |
| 106 | PRKCH | 0.62296181 |
| 107 | IKBKE | 0.62236971 |
| 108 | CCNB1 | 0.61660790 |
| 109 | PRKCZ | 0.60696421 |
| 110 | TAF1 | 0.60615346 |
| 111 | PRKG1 | 0.60570215 |
| 112 | FER | 0.59760364 |
| 113 | JAK3 | 0.59539680 |
| 114 | PRKAA2 | 0.58925282 |
| 115 | ROCK1 | 0.58884854 |
| 116 | FGFR2 | 0.58627409 |
| 117 | RET | 0.57301650 |
| 118 | CAMK2B | 0.57209671 |
| 119 | LYN | 0.57150935 |
| 120 | STK11 | 0.55790062 |
| 121 | CSNK1G2 | 0.55405462 |
| 122 | PRKCQ | 0.54971233 |
| 123 | FRK | 0.54435083 |
| 124 | LATS2 | 0.54298921 |
| 125 | PKN1 | 0.54027385 |
| 126 | MAPK12 | 0.53974070 |
| 127 | RPS6KA3 | 0.53371194 |
| 128 | NEK6 | 0.53285661 |
| 129 | FYN | 0.52686306 |
| 130 | HCK | 0.52684700 |
| 131 | RPS6KA2 | 0.51406286 |
| 132 | GRK6 | 0.51050547 |
| 133 | OXSR1 | 0.49654244 |
| 134 | PRKD2 | 0.48936308 |
| 135 | PRKAA1 | 0.48795864 |
| 136 | MAP2K6 | 0.47632996 |
| 137 | ROCK2 | 0.47616808 |
| 138 | TAOK1 | 0.47027273 |
| 139 | LCK | 0.46489481 |
| 140 | ZAP70 | 0.46370249 |
| 141 | BMPR1B | 0.45551683 |
| 142 | MAPK7 | 0.45323237 |
| 143 | STK3 | 0.44765484 |
| 144 | MAPKAPK5 | 0.44510404 |
| 145 | PRKACG | 0.44508778 |
| 146 | DAPK3 | 0.44042957 |
| 147 | MAPK10 | 0.43376901 |
| 148 | LMTK2 | 0.43372964 |
| 149 | MAPK3 | 0.42190557 |
| 150 | PRKACA | 0.42098531 |
| 151 | ADRBK1 | 0.42065785 |
| 152 | MAP2K1 | 0.41998302 |
| 153 | PRKG2 | 0.41737292 |
| 154 | NLK | 0.41712362 |
| 155 | KDR | 0.41616759 |
| 156 | MATK | 0.40968289 |
| 157 | ACVR1B | 0.40461165 |
| 158 | IGF1R | 0.39994812 |
| 159 | JAK2 | 0.38241406 |
| 160 | MAP2K2 | 0.36860305 |
| 161 | CSNK1G3 | 0.36331997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.91404240 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 3.25721357 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.19790630 |
| 4 | Morphine addiction_Homo sapiens_hsa05032 | 3.05999403 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.04243291 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.93965049 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.87718745 |
| 8 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.65966651 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.30340551 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.27277926 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.17421517 |
| 12 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.06340354 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.05943885 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.03064681 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.02452914 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.00500914 |
| 17 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.99471818 |
| 18 | * Renin secretion_Homo sapiens_hsa04924 | 1.93626683 |
| 19 | * Salivary secretion_Homo sapiens_hsa04970 | 1.85796538 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.85581699 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.85479054 |
| 22 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.76364935 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.76261237 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.74840575 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.73913414 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73822371 |
| 27 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.73380407 |
| 28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.70871643 |
| 29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.68836661 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.63665664 |
| 31 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.63044775 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.58746061 |
| 33 | Long-term potentiation_Homo sapiens_hsa04720 | 1.56986107 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55126089 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52973049 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50058800 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.49543825 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.47597953 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46998459 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.45001239 |
| 41 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.38303826 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.36186720 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35987257 |
| 44 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.34898532 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.34158032 |
| 46 | * Gap junction_Homo sapiens_hsa04540 | 1.33941113 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.33600804 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.32300961 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.31933216 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30703113 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.29954059 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29643272 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.18167901 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17478586 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.17470592 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16804807 |
| 57 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.13578857 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12366023 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.11680455 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.09176863 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09107086 |
| 62 | * Long-term depression_Homo sapiens_hsa04730 | 1.08154223 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.06560651 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 1.06521649 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05821119 |
| 66 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99555575 |
| 67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99021174 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.98539254 |
| 69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97988112 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96800894 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93897121 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.92948840 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92190600 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90784426 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.89030834 |
| 76 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.88640378 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88418673 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85211822 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84959895 |
| 80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82209185 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82113507 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81281012 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80273644 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78567573 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.77336627 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73274651 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72377865 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71502692 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71461560 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71340393 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70808247 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68590459 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.66220790 |
| 94 | Melanogenesis_Homo sapiens_hsa04916 | 0.65496436 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65259468 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64862401 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64860249 |
| 98 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64263303 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64033130 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61893133 |
| 101 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.61726038 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61252201 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59895346 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.59481386 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59346055 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59146216 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58626822 |
| 108 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58109626 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57734181 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55168915 |
| 111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54561083 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54342902 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53627655 |
| 114 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53534400 |
| 115 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53422600 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53333684 |
| 117 | Bile secretion_Homo sapiens_hsa04976 | 0.52901209 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52809782 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.51050355 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50754413 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.50524033 |
| 122 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50098355 |
| 123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49512467 |
| 124 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.46965556 |
| 125 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46878523 |
| 126 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46688171 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45437614 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44893929 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42967428 |
| 130 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42222220 |
| 131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42041979 |
| 132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41313965 |
| 133 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.40467125 |
| 134 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39794302 |
| 135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39601110 |
| 136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38354718 |
| 137 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38177653 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36934583 |
| 139 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36644150 |
| 140 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35778872 |
| 141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34838240 |
| 142 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34276945 |
| 143 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32821444 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.32569360 |
| 145 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32138450 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31997769 |
| 147 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31741541 |
| 148 | Melanoma_Homo sapiens_hsa05218 | 0.30776957 |
| 149 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27610943 |
| 150 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26050788 |
| 151 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.25369572 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24983468 |
| 153 | Focal adhesion_Homo sapiens_hsa04510 | 0.24911511 |
| 154 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23798501 |
| 155 | * Platelet activation_Homo sapiens_hsa04611 | 0.23610573 |

